Apimeds Pharmaceuticals US APUS Q1 2026 Annual earnings

FAQ

When did Apimeds Pharmaceuticals US report Q1 2026 earnings?

Apimeds Pharmaceuticals US (APUS) reported Q1 2026 earnings on May 26, 2026 before market open.

What were Apimeds Pharmaceuticals US's Q1 2026 revenue and EPS?

Apimeds Pharmaceuticals US reported eps of $-2.26 for Q1 2026.

How did Apimeds Pharmaceuticals US's Q1 2026 results compare year-over-year?

Compared to the same quarter a year prior, eps declined 4420.0% from $-0.05.

Where can I find Apimeds Pharmaceuticals US's Q1 2026 SEC filings?

You can read the 10-K periodic report (0001213900-26-051139) directly on SEC EDGAR. The filing index links above go to sec.gov.